Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform
October 26, 2023 06:59 ET
|
Generation Bio Co.
70% of circulating and splenic T cells positive for mRNA expression in humanized mice with less than 8% delivery to off-target immune cells Stealth properties of cell-targeted lipid nanoparticle...
Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA
October 18, 2023 06:59 ET
|
Generation Bio Co.
– Immune-quiet DNA (iqDNA) is a novel variant of closed-ended DNA (ceDNA) that evades host innate immune detection in both mice and non-human primates (NHPs) with a systemic cytokine profile and...
Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit
September 19, 2023 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference
August 03, 2023 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Reports Second Quarter 2023 Financial Results
August 02, 2023 16:15 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Present at the 2023 Jefferies Healthcare Conference
May 31, 2023 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results
May 10, 2023 16:15 ET
|
Generation Bio Co.
Company entered into strategic collaboration with Moderna to use Generation Bio’s proprietary non-viral genetic medicine delivery system for two liver disease programs and to co-develop novel...
Generation Bio to Present at the JMP Securities Life Sciences Conference
May 09, 2023 16:15 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer
April 05, 2023 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...